Hikma Ventures

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

We established Hikma Ventures in 2015 to broaden Hikma’s offerings and tap into opportunities in the growing digital health and life sciences space.

Corporate venture armUnited Kingdomhikmaventures.comSince 2025-04-22

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$100M

across 1 round

LATEST ROUND

Series C · $100M · 2025-04-22

CO-INVESTORS

named beside it

Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

Biolinq[ PART ]

Biolinq sells wearable biosensor technology that monitors glucose levels for health and metabolic insights.

Series C$100M2025-04-221 [ HISTORY ]

Company	Round	Amount	Announced	Role
Biolinq Biolinq sells wearable biosensor technology that monitors glucose levels for health and metabolic insights.	Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$100M	2025-04-22	[ PART ]